Werewolf Therapeutics, Inc.

NASDAQ
HOWL
Stock
Yield per half year: -13.48%
Dividend yield: 0%
Sector: Healthcare

Reporting Werewolf Therapeutics, Inc.

Capitalization

2019 2020 2021 2022 2023 2024 LTM Average for 5 years CAGR 5
Capitalization, bln $
0.3278 0.1316 0.1015 0.0895 0.1870 -32.35
Revenue, bln $
0.0041 0.0164 0.0199 0.0019 0.0019 0.0106 -17.49
Net profit, bln $
-0.01 -0.015 -0.05 -0.0516 -0.0374 -0.0705 -0.0705 -0.0449 36.28
EV, bln $
-0.0148 -0.09 0.0779 -0.063 0.0434 -0.0363 -0.0363 -0.0136 -16.61
EBIT, bln $
-0.0099 -0.0224 -0.0501 -0.0561 -0.0342 -0.0659 -0.0659 -0.0457 24.09
EBITDA, bln $
-0.0095 -0.0223 -0.0501 -0.055 -0.0325 -0.064 -0.064 -0.0448 23.47
OIBDA $
-0.0217 -0.0502 -0.0594 -0.0356 -0.0671 -0.0671 -0.0468 25.33
Book value, bln $
-0.0243 -0.0519 0.1528 0.1223 0.1114 0.0734 0.0734 0.0816 -207.18
FCF, bln $
-0.01 -0.019 -0.043 -0.0442 -0.0334 -0.0564 -0.0564 -0.0392 24.31
Operating Cash Flow, bln $
-0.0095 -0.0186 -0.0429 -0.0406 -0.0326 -0.0562 -0.0562 -0.0382 24.75
Operating profit, bln $
-0.01 -0.022 -0.05 -0.0561 -0.0405 -0.0736 -0.0736 -0.0484 27.32
Operating expenses, bln $
0.0099 0.0224 0.0501 0.0725 0.0604 0.0755 0.0755 0.0562 27.51
CAPEX, bln $
0.000266 0.001 0.000498 0.0036 0.000769 0.000254 0.000254 0.0012 -23.97


Balance sheet

2019 2020 2021 2022 2023 2024 LTM Average for 5 years CAGR 5
Cash, bln $
0.0179 0.0926 0.1575 0.1293 0.1343 0.1122 0.1122 0.1252 3.91
Accounts Receivable $
0.0069 0.0014 0.0014 0.0042 -54.96
Total Current Assets $
0.0181 0.0929 0.1611 0.1402 0.1384 0.1131 0.1131 0.1291 4.01
Net assets, bln $
0.0181 0.0929 0.1611 0.009 0.1566 0.009 0.0875 53.97
Assets, bln $
0.0217 0.0964 0.1793 0.1602 0.1748 0.1269 0.1269 0.1475 5.65
Short-Term Debt $
0.000595 0.000677 0.0011 0.0042 0.0083 0.0016 0.0016 0.0032 18.77
Long-Term Debt $
0.0327 0.0261 0.0261 0.0294 -10.66
Liabilities, bln $
0.046 0.1483 0.0265 0.0379 0.0635 0.0535 0.0535 0.0659 -18.45
Net debt, bln $
-0.0148 -0.09 -0.1419 -0.1146 -0.0824 -0.1012 -0.1012 -0.1060 2.37
Debt, bln $
0.0031 0.0025 0.0157 0.0147 0.0519 0.011 0.011 0.0192 34.49
Interest Income $
0.0001 0.000104 0.0019 0.0045 0.0017 159.00
Interest Expense, bln $
0.000372 0.000101 0.000216 0.0011 0.0031 0.0047 0.0047 0.0018 115.55
Net interest income, bln $
-0.000372 0.0001 0.000104 0.0019 0.0045 0.0045 0.0012 -264.64
Amortization, bln $
0.000395 0.00015 0.000216 0.0011 0.0018 0.0018 0.0018 0.0010 64.38
Cost of production, bln $
0.000463 0.000777 0.000735 0.0025 0.0389 0.0018 0.0087 142.59
Inventory $
0


Share

2019 2020 2021 2022 2023 2024 2025 LTM Average for 5 years CAGR 5
EPS -2.03 -3.15 -10.94 -1.79 -1.05 -1.61 -1.61 -3.7080 -12.56
Share price 18.21 3.42 3.86 1.48 1.29 1.29 5.65 -41.11
Number of shares, mln 8 8 18 28.86 35.65 43.86 43.86 26.87 40.54
FCF/share -1.09 -2.14 -2.35 -1.53 -0.9364 -1.29 -1.29 -1.6493 -9.63


Efficiency

2019 2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
ROE, % 44.97 20.16 -400.15 -37.48 -31.98 -76.33 -76.33 17.60 -105.1560 -230.51
ROA, % -84.09 -25.47 -146.51 -30.38 -22.3 -46.74 -46.74 5.71 -54.2800 12.91
ROIC, % -339.19 17.65 -339.1900 0.00
ROS, % -1199.78 -314.4 -187.37 -3740.85 -3740.85 -3740.85 13.36 -1836.6500 25.54
ROCE, % -50.6 -24.59 -29.92 -41.14 -22.02 -58.93 -89.74 -89.74 29.73 -48.3500 24.57
EBIT margin -1207.5 -341.78 -171.63 -3493.85 -3493.85 -3493.85 18.53 -1741.7220 23.68
EBITDA margin -1207.5 -335.05 -162.79 -3397.61 -3397.61 -3397.61 26.10 -1700.1120 22.99
Net margin -1199.78 -314.4 -187.37 -3740.85 -3740.85 13.36 -1360.6000 32.88
Operational efficiency, % -1207.5 -341.78 -203.09 -3904.19 -3904.19 -3904.19 16.64 -1912.1500 26.45
FCF yield, % -10.28 -29.36 -32.89 -24.1767 47.35


Coefficients

2019 2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
P/E
-8.48 0.42 -2.72 0.42 69.12 -3.5933 -31.55
P/BV
1.9 0.4223 1.13 0.8845 0.8845 8.87 1.08 -17.40
P/S
52.99 3.15 6.31 34.44 34.44 8.05 24.22 -10.21
P/FCF
-9.73 -3.41 -2.02 -2.68 -1.59 -1.59 8.97 -3.8860 -30.39
E/P
-0.1179 -0.3425 -0.3682 -0.4175 -0.7879 -0.7879 0.03 -0.4068 46.21
EV/EBIT
1.48 5.99 -3.66 1.12 -1.27 0.5513 0.5513 0.5513 88.11 -0.5415 -168.48
EV/EBITDA
1.55 4.05 -1.56 1.15 -1.34 0.567 0.567 53.63 0.5734 -32.51
EV/S
44.22 -3.84 2.18 -19.26 -19.26 -19.26 8.36 0.8080 -184.69
EV/FCF
1.5 4.69 -4.23 1.42 -1.3 0.6433 0.6433 0.6433 21.77 -0.5647 -168.61
Debt/EBITDA
-0.3288 -0.1142 -0.314 -0.2672 -1.6 -0.1716 -0.1716 -0.1716 2.61 -0.5049 -11.38
Netdebt/Ebitda
1.55 4.05 2.84 2.09 2.54 1.58 1.58 1.58 0.49 2.13 -11.07
Debt/Ratio
0.1447 0.0264 0.0874 0.0916 0.297 0.0866 0.0866 0.0866 0.24 0.1298 -0.18
Debt/Equity
-0.1291 -0.049 0.1025 0.12 0.4662 0.1498 0.7295 0.7295 2.82 0.3136 48.07
Debt/Net Income
-0.2854 -0.1701 -0.3147 -0.2848 -1.39 -0.1559 -0.1559 -0.1559 10.75 -0.4603 -13.11
PEG
-0.6575 -0.6575 -67.37 -0.6575 0.00
Beta
-24.54 1.07 -3 -0.4319 -0.4319 -0.03 -6.7255 -63.58
Altman Index
1.47 0 0.0782 0.1835 -0.3409 -0.3409 12.59 0.3477 -169.39


Dividends

2022 LTM Industry average Average for 5 years CAGR 5
Dividend
0
Dividend yield, %
0 1.71
Dividends / profit, %
0 0 155.02


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Other

2019 2020 2021 2022 2023 2024 LTM CAGR 5
Total Debt
0.002 0.0053 62.79
CAPEX/Revenue, %
12.01 22.02 3.86 13.47 13.47 2.91
Staff, people
42 46 47 3.82